Connect your AI

BillionToOne, Inc. BLLN Deferred revenue, net of current portion

Deferred revenue, net of current portion at other companies

Guardant HealthGH

——

Natera, Inc.NTRA

——

ExelixisEXEL

——

Crinetics PharmaceuticalsCRNX

——

Other financials

Income statement

Revenue$108.4M+83.8%

Gross profit$79.1M+108%

Operating income$17.8M+870%

Net income$18.0M+551%

EPS (diluted)$0.34+187%

Balance sheet

Cash & equivalents$537.5M+181%

Total debt$144.2M—

Total equity$505.6M+300%

Total assets$700.7M—

Cash flow

Operating cash flow$15.4M+488%

CapEx$4.5M+90.5%

Free cash flow$11.0M+3,842%

Valuation

Market cap$4.84B—

Profitability

Gross margin70.4%—

Operating margin-96.9%—

Net margin8.4%—

FCF margin-83.4%—

Returns & leverage

Debt / equity0.3×—

Current ratio10.9×—

Where this comes from

Reported directly by BillionToOne, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.

The official record: BillionToOne, Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BillionToOne, Inc. 's deferred revenue, net of current portion.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is BillionToOne, Inc. 's deferred revenue, net of current portion?: BillionToOne, Inc. (BLLN) reported deferred revenue, net of current portion of $0 in Q1 2026.